Cannulation practices at haemodialysis initiation via an arteriovenous fistula or arteriovenous graft.


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 20 8 2019
medline: 6 10 2020
entrez: 20 8 2019
Statut: ppublish

Résumé

A functioning long-term vascular access is required for haemodialysis therapy; however, establishing this can be challenging in the setting of advanced age and vessels damaged by diabetes. Complications include the inability to insert two needles for the treatment resulting in miscannulation trauma and in some cases insertion of a temporary central venous access device. The broad objective of this review is to define the evidence base regarding cannulation practices in the initiation of haemodialysis via an arteriovenous fistula or an arteriovenous graft. This review uses the framework recommended by the Joanna Briggs Institute and the process by which papers were included or excluded followed the standard Preferred Reporting Items for Systematic Reviews and Meta-Analyses group approach. A total of 20 primary research studies met the inclusion criteria. Cannulation in the 10- to 15-week period rather than delaying past this time frame is associated with the best outcomes. New vascular access given time to mature through single-needle haemodialysis treatments may improve long-term patency. Duplex ultrasound mapping prior to initiation of cannulation supports the clinical decision-making process on timing of and selection of cannulation sites. Cannulation trauma at the initiation of haemodialysis could potentially be reduced with a strategy of incremental haemodialysis using single-needle treatment supported with duplex ultrasonography assessment to 'map' the vascular access as a guide for clinicians prior to cannulation initiation.

Identifiants

pubmed: 31423945
doi: 10.1177/1129729819869093
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

573-581

Auteurs

Kathleen Hill (K)

University of South Australia, Adelaide, SA, Australia.

Rebecca Sharp (R)

University of South Australia, Adelaide, SA, Australia.

Jessie Childs (J)

University of South Australia, Adelaide, SA, Australia.

Adrian Esterman (A)

University of South Australia, Adelaide, SA, Australia.

Richard Le Leu (R)

Central and Northern Adelaide Renal and Transplantation Service, Adelaide, SA, Australia.

Rajiv Juneja (R)

Southern Adelaide Local Health Network, Adelaide, SA, Australia.

Shilpa Jesudason (S)

Central and Northern Adelaide Renal and Transplantation Service, Adelaide, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH